Back to FARALLON CAPITAL MANAGEMENT, L.L.C. FARALLON CAPITAL MANAGEMENT, L.L.C.

AGIOAGIO
Showing 8 of 27 quarters

Position history for FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.'s holdings in AGIOS PHARMACEUTICALS INC

FARALLON CAPITAL MANAGEMENT, L.L.C. holds 5.9M shares of AGIO (AGIOS PHARMACEUTICALS INC), worth $219.6M as of 2026-Q2. The position was increased (+4.1% shares). AGIO represents 1.0% of FARALLON CAPITAL MANAGEMENT, L.L.C.'s portfolio.

Current Value

$219.6M

Current Shares

5.9M

Total Value Change

-$31.9M

Total Shares Change

+256,534

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
5.9M
+4.1%
$219.6M1.0%$37.11
50
2026-Q1
Increased
5.7M
+10.2%
$192.3M1.0%$33.83
53
2025-Q4
Decreased
5.2M
-10.8%
$140.4M0.6%$27.22
0
2025-Q3
Increased
5.8M
+0.2%
$232.1M0.9%$40.14
43
2025-Q2
Increased
5.8M
+1.2%
$191.8M0.8%$33.26
43
2025-Q1
Increased
5.7M
+0.5%
$167M0.8%$29.30
43
2024-Q4
Increased
5.7M
+0.2%
$186.5M0.8%$32.86
43
2024-Q3
Increased
5.7M
+0.1%
$251.5M1.1%$44.43
48

Other major holders of AGIO: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock, Inc., Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used